Status | Study |
Recruiting |
Study Name: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2012-04-05 Interventions: Drug: Hydroxychloroquine 100 m |
Recruiting |
Study Name: Clinical Diagnosis of Acute Porphyria Condition: Hereditary Coproporphyria (HCP) Acute Intermittent Porphyria (A Date: 2012-02-16 |
Recruiting |
Study Name: Longitudinal Study of the Porphyrias Condition: Acute Porphyrias Cutaneous Porphyrias Date: 2012-02-13 |
Completed |
Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2011-01-26 Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |
Completed |
Study Name: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2008-01-10 Interventions: Drug: Deferasirox 250 mg of deferasirox once daily for 6 months |
Completed |
Study Name: Porphozym in the Treatment of Acute Attacks in AIP Condition: Acute Intermittent Porphyria Date: 2007-01-04 Interventions: Drug: recombinant human porphobilinogen deaminase (Porphozym) |
Completed |
Study Name: Risk Factors of Porphyria Cutanea Tarda (PCT) Condition: Porphyria Cutanea Tarda Date: 2005-09-13 |
Completed |
Study Name: Study of the Pathogenesis of Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2000-04-06 |
Completed |
Study Name: Study of Nutritional Factors in Porphyria Condition: Porphyria Date: 2000-02-24 |
Completed |
Study Name: Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria Condition: Porphyria Date: 2000-02-24 Interventions: Drug: heme arginate Drug: tin mesoporphyri |